Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2020

Peptidoglycan editing provides immunity to Acinetobacter
baumannii during bacterial warfare
Nguyen-Hung Le
Washington University School of Medicine in St. Louis

Gisela Di Venanzio
Washington University School of Medicine in St. Louis

Juvenal Lopez
Washington University School of Medicine in St. Louis

Seth W Hennon
Washington University School of Medicine in St. Louis

Mario F Feldman
Washington University School of Medicine in St. Louis

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Le, Nguyen-Hung; Di Venanzio, Gisela; Lopez, Juvenal; Hennon, Seth W; Feldman, Mario F; and et al,
,"Peptidoglycan editing provides immunity to Acinetobacter baumannii during bacterial warfare." Science
Advances. 6,30. . (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9425

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Nguyen-Hung Le, Gisela Di Venanzio, Juvenal Lopez, Seth W Hennon, Mario F Feldman, and et al

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/9425
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MICROBIOLOGY

Peptidoglycan editing provides immunity
to Acinetobacter baumannii during bacterial warfare

Nguyen-Hung Le1, Katharina Peters2, Akbar Espaillat3, Jessica R. Sheldon4, Joe Gray5,
Gisela Di Venanzio1, Juvenal Lopez1, Bardya Djahanschiri6, Elizabeth A. Mueller7,
Seth W. Hennon1, Petra Anne Levin7, Ingo Ebersberger6,8,9, Eric P. Skaar4, Felipe Cava3,
Waldemar Vollmer2, Mario F. Feldman1*

Peptidoglycan (PG) is essential in most bacteria. Thus, it is often targeted by various assaults, including interbacterial
attacks via the type VI secretion system (T6SS). Here, we report that the Gram-negative bacterium Acinetobacter
baumannii strain ATCC 17978 produces, secretes, and incorporates the noncanonical d-amino acid d-lysine into its
PG during stationary phase. We show that PG editing increases the competitiveness of A. baumannii during bacterial warfare by providing immunity against peptidoglycan-targeting T6SS effectors from various bacterial competitors. In contrast, we found that d-Lys production is detrimental to pathogenesis due, at least in part, to the
activity of the human enzyme d-amino acid oxidase (DAO), which degrades d-Lys producing H2O2 toxic to bacteria.
Phylogenetic analyses indicate that the last common ancestor of A. baumannii had the ability to produce d-Lys.
However, this trait was independently lost multiple times, likely reflecting the evolution of A. baumannii as a human pathogen.
INTRODUCTION

Peptidoglycan (PG) is a major component of the bacterial cell envelope. Layers of PG surround the cytoplasmic membrane, maintaining
cell shape and providing resistance to osmotic stress. PG is composed
of glycan chains of alternating N-acetylglucosamine (GlcNAc) and
N-acetylmuramic acid (MurNAc) that are connected through
MurNAc-attached peptides (1). Despite its rigidity, PG is necessarily
a dynamic structure, requiring constant turnover to enable fundamental processes such as growth and cell division (2). PG synthesis
is a multistep process. The PG precursor lipid II, which consists of a
GlcNAc-MurNAc pentapeptide (l-Ala-d-iGlu-mDAP-d-Ala-d-Ala
in Gram-negative bacteria) linked to a lipid carrier, is synthesized at the
cytoplasmic membrane and subsequently translocated into the outer
leaflet of the cytoplasmic membrane. Glycan chains are then polymerized by glycosyltransferases, and peptide cross-links are formed
through transpeptidation reactions catalyzed by dd-transpeptidases
and ld-transpeptidases.
Because of its essentiality, the bacterial cell wall is targeted by
various potentially fatal threats, including attacks from bacterial
competitors. Competition among Gram-negative bacteria is largely
mediated by the type VI secretion system (T6SS) (3). The T6SS is a
dynamic nanomachine structurally related to contractile phage tails,
and it is used to deliver toxic effector proteins, including PG hydro1
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lases, from an attacking cell (predator) to nearby competitors (prey)
in a contact-dependent manner (4–6). Immunity to T6SS-dependent
killing is accomplished by the expression of immunity proteins,
which specifically bind and inactivate their cognate effector. The
limited repertoire of immunity proteins encoded by one bacterium
is insufficient to protect against the large diversity of T6SS effectors
encoded by bacterial predators. Therefore, the primary role of immunity proteins is to avoid lethal interactions between sister cells
(7–9). General resistance mechanisms to prevent T6SS-dependent
killing by nonkin competitors remain poorly characterized (10).
Additional threats to the integrity of the bacterial cell wall include
the host immune system, antibiotics, and osmotic stress (11–13).
Constant exposure to these threats has exerted selective pressure
favoring bacterial species capable of modifying their PG to evade or
withstand fatal threats. These modifications can occur during PG
precursor synthesis or after PG precursors are incorporated into the
growing cell wall meshwork (14). PG modifications enabling immune
evasion and resistance to antibiotics have been extensively studied
and generally include chemical modifications to the glycan backbone
or changes in pentapeptide composition or degree of cross-linking
(12, 14–18). In addition, PG editing with noncanonical d-amino acids
(NCDAAs) has been shown to make bacteria more resistant to osmotic stress (19). NCDAAs have been best characterized in Vibrio
cholerae, which modifies up to ~5% of its PG subunits with d-Met
during stationary phase. In addition to incorporating d-Met into its
PG, this organism produces and secretes a wide variety of NCDAAs
to millimolar concentrations (19). Some of the secreted NCDAAs
inhibit the growth of diverse bacteria at physiological concentrations,
making NCDAAs important mediators of interbacterial competition
(20). It is currently unknown whether PG editing with NCDAAs plays
an important role during bacterial warfare.
The Gram-negative bacterial pathogen Acinetobacter baumannii
has a remarkable ability to withstand antibiotic treatment and persist in health care settings. As such, it is categorized by the World
Health Organization and the U.S. Centers for Disease Control and
Prevention as a critical priority for the research and development of
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novel antimicrobial therapies. Given the remarkable ability of
A. baumannii to withstand a wide variety of environmental stressors
(21), we investigated whether this organism modifies its PG during
stationary phase, as has been reported in other bacterial species
(1, 19, 22). To this end, we purified PG from Ab17978 grown to
exponential phase (PGexp) or stationary phase (PGstat), digested it
with muramidases, and analyzed the resulting muropeptides by
high-performance liquid chromatography (HPLC). The muropeptide profile obtained from PGexp is similar to that of Escherichia coli
(Fig. 1A and figs. S1 and S2). However, the HPLC chromatogram
derived from PGstat showed five unique peaks (Fig. 1A). Mass spectrometry (MS) analysis identified these products as monomeric or
cross-linked muropeptides containing a lysine residue (Lys) in the
fourth (l-Ala-d-iGlu-mDAP-lysine, hereafter referred to as “Tri-Lys”)
or fifth (l-Ala-d-iGlu-mDAP-d-Ala-lysine, hereafter referred to as
“Tetra-Lys”) position (Fig. 1B, fig. S8, and table S1). Quantification
of HPLC profiles showed that the Tri-Lys muropeptide and its cross-
linked forms constitute ~24% of the total muropeptides of PGstat
(Fig. 1A and table S2). Lys-containing muropeptides were also present
in PGexp but in a considerably lower amount (~6% of total muropeptides). In contrast, Tetra-Lys muropeptides were unique to PGstat
and accounted for ~10% of the total muropeptides. Together, our
results indicate that during stationary phase, Ab17978 is capable of
modifying about one-third of its PG with Lys.
MS is unable to differentiate l-Lys from d-Lys. Previous work
showed that bacteria that produce and incorporate NCDAAs into
their PG meshwork also secrete NCDAAs into the culture supernatant at millimolar concentrations (19, 22). Thus, d-Lys secretion by
Ab17978 would suggest editing with the d-enantiomer. We developed

Fig. 1. Ab17978 incorporates d-Lys into its PG at stationary phase. (A) Chroma
tograms of purified muropeptides from Ab17978 during stationary (stat.) and exponential (exp.) phase. Main muropeptides (no. 1-11B) are numbered according to
Boll et al., 2016 (43). d-Lys–containing muropeptides (a to e) were identified by MS.
Proposed muropeptide structures are shown in fig. S2. mA.U, milli absorbance units.
(B) Proposed structures of d-Lys–modified muropeptides a to e. GM, N-acetylglucosamine-
N-acetylmuramitol; l-Ala, l-alanine; d-iGlu, d-isoglutamate; m-Dap, meso-diaminopimelic
acid; Lys, lysine; d-Ala, d-alanine. “Tri” or “Tetra” indicates the number of amino acids
in the peptides chain preceding Lys.
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a colorimetric assay using the d-Lys–specific oxidase AmaD from
Pseudomonas putida to detect and quantify the concentration of
d-Lys in culture supernatants of Ab17978 (Fig. 2A) (23). Using our
AmaD assay, we determined that Ab17978 produces and secretes
d -Lys into culture supernatants to a concentration of ~0.3 mM
(Fig. 2B), which is comparable to levels of NCDAA secreted by other
bacterial species (19, 24). d-Lys secretion has not been reported in
Acinetobacter, leading us to investigate how d-Lys is produced.
Amino acid racemases are enzymes that catalyze the conversion
between l-amino acids and d-amino acids. Ab17978 encodes five
putative amino acid racemases, only one of which is predicted to
have a signal peptide (ACX60_11360, hereafter referred to as “RacK”).
To identify the racemase involved in d-Lys production, we constructed mutant strains of Ab17978 lacking each racemase and determined the levels of d-Lys in their culture supernatants. Deletion
of only one racemase, RacK, completely abrogated d-Lys secretion
(fig. S3). Complementation of the racK gene (RacK+) restored d-Lys
secretion to levels comparable with wild-type (WT) Ab17978 (Fig. 2B).
Having identified RacK as responsible for d-Lys production, we determined whether d-Lys was the Lys enantiomer incorporated into
the PG of Ab17978 during stationary phase. We analyzed muropeptides from Ab17978 WT, RacK, and RacK+ by HPLC. PGstat from
RacK lacked the peaks corresponding to Tri-Lys and Tetra-Lys
subunits, all of which were present in the WT and RacK+ strains
(Fig. 2C). Together, our results demonstrate that Ab17978 secretes
d-Lys to millimolar concentrations and that PG editing is dependent
on the production of d-Lys by RacK. Because RacK is predicted to
localize to the periplasm, we propose that PG editing with NCDAAs
in Ab17978 occurs in the periplasm, as has been suggested for
V. cholerae (19, 22). Previous transcriptomics study in Ab17978
showed that racK was also up-regulated in biofilms compared to
cells in exponential phase (25).
Virtually all bacteria have the ability to incorporate NCDAAs,
either produced by their own racemases or present in the environment,
into their PG meshwork (14, 26, 27). This can be accomplished by
the activity of dd- or ld-transpeptidases (22, 27–29). Previous work
has demonstrated that PG editing with NCDAAs affects cell physiology and decreases both dd– and ld–cross-links, likely by competing with transpeptidase activity (19, 22, 28–30). Consistently, PG of
Ab17978 WT and RacK+ showed a lower percentage of muropeptides in cross-linking compared with Ab17978 RacK, indicating that
d-Lys interferes with the PG cross-linking activity of transpeptidases (table S4). Previous studies have shown that PG cross-linking
enhances a bacterium’s ability to withstand stress (31, 32). Thus, we
next tested whether PG editing with d-Lys affected the ability of
Ab17978 to withstand a variety of environmental stressors. We found
that Ab17978 RacK was nearly indistinguishable from WT in
growth under pH and osmotic stress as well as cell morphology (fig.
S4), which suggest an alternative role for d-Lys in Acinetobacter.
NCDAAs are considered part of the warfare between bacterial species,
as certain secreted d-amino acids can inhibit the growth of diverse
bacteria (20). However, we found that the concentration of d-Lys
present in the spent media of Ab17978 was not sufficient to inhibit the
growth of Pseudomonas aeruginosa PAO1, Acinetobacter nosocomialis
strain M2 (M2), or A. baumannii strain 19606 (Ab19606) (fig. S5).
We then hypothesized that PG editing with d-Lys could constitute a protective mechanism against T6SS-mediated attacks from
nonkin bacteria. In this model, PG editing masks the target of T6SS
PG hydrolase effectors, similar to how bacteria become resistant
2 of 8
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Fig. 2. Racemase RacK is responsible for d-Lys secretion and PG editing. (A) Overview of the colorimetric assay used to quantify d-Lys secretion. Purified d-Lys oxidase
AmaD from P. putida catalyzes the oxidative deamination of d-Lys to release 6-amino-2-oxohexanoate, hydrogen peroxide (H2O2), and ammonium (NH3). H2O2 produced
was then quantified by treatment with horseradish peroxidase (HRP) and a fluorophore dye. The amount of fluorescence is converted to d-Lys concentration through a
standard curve. (B) Quantification of d-Lys present in supernatant fractions of Ab17978 WT, 17978RacK, and the complemented strain (17978 RacK+). Data represent
means ± SD of three biological replicates. (C) Chromatograms of purified, stationary phase muropeptides from the indicated strains. Muropeptide structures are shown
in fig. S2.

Fig. 3. PG editing protects A. baumannii from T6SS amidase effector. (A) PG editing with d-Lys provides protection to T6SS-dependent attack from P. aeruginosa
PAO1. Competition assay between PAO1, S. marcescens (Serratia), or A. nosocomialis M2 as predator and A. baumannii strains expressing (Ab17978 WT or UPAB1 RacK+)
or not expressing (Ab17978RacK or UPAB1 WT) RacK as prey. Bar graphs represent the means ± SD from four biological replicates. (B) Nonedited (TetraTetra) and edited
muropeptides (TetraTri-d-Lys) were treated together with purified PAO1 amidase effector Tse1. Reaction products were analyzed by HPLC at time t = 0 (Ctrl), t = 0.5 min,
and t = 5 min. Undigested muropeptides were quantified, and specific activity of Tse1 against TetraTetra and TetraTri-d-Lys was calculated. Specific activity values shown
on graph are expressed in milligrams of muropeptide degraded/min/Tse1 concentration. Data present means ± SD of two biological replicates. Statistical analyses were
performed using the Student’s unpaired t test, *P < 0.05, **P < 0.01, and ***P < 0.001.

to antibiotics by modifying the structure of the antibiotic target.
The H1-T6SS of P. aeruginosa PAO1 delivers at least two PG hydrolase effectors into target cells: the amidase (or d,l-endopeptidase)
Tse1 and the muramidase Tse3 (4). Thus, to test our hypothesis, we
performed bacterial competition assays with P. aeruginosa PAO1 as
the predator and Ab17978 WT or ∆RacK as the prey. We found that
∆RacK was ~15-fold more susceptible to T6SS killing compared
with WT Ab17978 (Fig. 3A). Consistently, UPAB1 RacK+ showed
~25-fold higher survival than WT UPAB1 when co-incubated with
PAO1 (Fig. 3A and fig. S6). Similarly, we observed that PG editing
by d-Lys increased the survival of A. baumannii against Serratia
Le et al., Sci. Adv. 2020; 6 : eabb5614
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marcescens and A. nosocomialis M2 (Fig. 3A). Collectively, these
results indicate that PG editing with d-Lys provides A. baumannii
immunity against T6SS-dependent attacks from diverse bacteria.
To gain better insight into the mechanism of PG editing–based
immunity to T6SS-mediated attacks, we compared the activity of
P. aeruginosa PAO1 Tse1 toward nonedited (TetraTetra) and d-Lys–
edited (TetraTri-d-Lys) dimeric muropeptides. A mix of both muro
peptides was incubated with purified Tse1, and samples were taken
at different time points and analyzed by HPLC (Fig. 3B). At 0.5 min,
we found that most of the TetraTetra muropeptides were hydrolyzed by Tse1, whereas nearly 40% of TetraTri-d-Lys remained
3 of 8

SCIENCE ADVANCES | RESEARCH ARTICLE

Fig. 5. Evolutionary history of A. baumannii RacK. The presence of RacK (red
boxes) is limited to individual lineages within A. baumannii, while it is ubiquitously
present in the closely related species Acinetobacter seifertii, Acinetobacter pitti, and
Acinetobacter dijkshoorniae. Whenever present, RacK is embedded within the same
four flanking genes (colored boxes) throughout the Acb complex. This gene order
is maintained in the species and strains where RacK is missing. The phylogenetic
relationships of RacK (left tree) and of the four flanking genes (right tree) are congruent, indicating that the contemporary patchy distribution of RacK is a consequence of recurrent and lineage specific gene loss (marked by the red crosses). ATCC,
American Type Culture Collection.

Fig. 4. d-Lys secretion impairs A. baumannii virulence. (A) RacK is detrimental in a
murine model of acute pneumonia. Mice were intranasally inoculated with either the
Ab17978 WT or RacK (left) or the UPAB1 WT or RacK+ (right). Following 36 hours of infection, the bacterial burdens of the kidneys, heart, liver, spleen, lungs, and blood were
determined. Each symbol represents an individual mouse. Statistical analyses were
performed using the Mann-Whitney U test, and LOD represents the limit of detection. (B) DAO has increased antibacterial activity on A. baumannii strains having RacK.
WT and RacK Ab17978 (left) or WT and RacK+ UPAB1 (right) were incubated with DAO
or DAO + catalase for 4.5 hours, and CFU were enumerated. Bar graphs represent the
means ± SD of four biological replicates. Statistical analyses were performed using the
unpaired Student’s t test, *P < 0.05, **P < 0.01, and ****P < 0.0001.

uncleaved. We observed a ~4-fold decrease in the specific activity of
Tse1 toward the d-Lys–modified muropeptide compared with the
nonedited muropeptide, consistent with the results of our bacterial
competition assays (Fig. 3A). Together, these results support the
hypothesis that PG editing in Ab17978 provides an immunity protein–
independent mechanism to prevent T6SS-dependent killing by masking the target PG from the injected effector.
Some bacterial species modify their PG to counteract the host
innate immune response (12, 33). We examined whether the presence of RacK would affect A. baumannii pathogenesis in the murine
acute pneumonia model of infection (34). Ab17978 or UPAB1 strains
either encoding or lacking RacK were introduced by intranasal inoculation, and bacterial burdens were enumerated 36 hours after
infection. Unexpectedly, strains unable to produce d-Lys showed
substantially higher bacterial burdens [1 to 2 log colony-forming
units (CFU)] in the kidney, heart, and liver, suggesting that d-Lys
production is disadvantageous for bacterial dissemination (Fig. 4A).
Le et al., Sci. Adv. 2020; 6 : eabb5614
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Recent findings have suggested that the d-amino acid oxidase (DAO),
expressed by human neutrophils, macrophages, and epithelial cells,
contributes to host defense against various pathogens through the
production of H2O2, a by-product of the DAO-dependent oxidative
deamination of d-amino acids (24, 35, 36). Thus, we hypothesized
that d-Lys–producing bacteria would be more susceptible to DAO-
dependent killing. To test this, we incubated stationary phase Ab17978
or UPAB1 strains either encoding or lacking RacK with purified
DAO and enumerated surviving CFU after 4.5 hours. DAO showed
significant antibacterial activity against A. baumannii strains harboring RacK, resulting in a 103-fold reduction in CFU compared with
strains not producing d-Lys (Fig. 4B). The addition of purified catalase,
an enzyme that eliminates H2O2, provided full protection against DAO,
indicating that A. baumannii killing by DAO is H2O2-dependent.
Together, our results demonstrate that d-Lys production is detrimental to pathogenesis, at least in part, due to DAO activity.
The benefit of PG editing in bacterial competition and detriment to pathogenesis present an interesting evolutionary paradox,
making it difficult to predict whether natural selection would favor
Acinetobacter strains capable or incapable of modifying their PG.
To this end, we performed a phylogenetic profiling analysis of RacK
across 3052 Acinetobacter strains representing 53 species. We found
that RacK is largely confined to the Acinetobacter calcoaceticus/
baumannii (Acb)–complex, occurring only sporadically in other
species (fig. S7). Within the Acb-complex, RacK is prevalent in the
two earliest branching lineages, suggesting its presence in the last
common ancestor of the Acb-complex (Fig. 5). Furthermore, RacK
is always flanked by the same four genes, and this gene order is
maintained irrespective of the presence of RacK (Fig. 5). A phylogenetic analysis provided no evidence that the evolutionary history
differs between the four flanking genes and RacK, indicating that
the five genes were likely present in the last common ancestor of
A. baumannii. We found that only 7% of A. baumannii strains encode
4 of 8
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infections (36–39). Despite the competitive advantages conferred by
the expression of RacK during interbacterial competition, modern
clinical Ab (Acinetobacter baumannii) strains and other Acinetobacter
species of the Acb-complex have relinquished their copy of the racK
gene. Strains from the most common lineages of clinical A. baumannii
strains, such as international clone 1 (IC1), IC2, and IC3, do not
carry the racK gene. This is reminiscent of the loss of the T6SS via
genetic disruptions to the T6SS gene locus or the accumulation of
inactivating point mutations in ~40% of A. baumannii clinical isolates
(40, 41). Both PG editing and a functional T6SS are crucial in the
environment but appear to impose a fitness cost during infection.
These examples illustrate the multiple adaptations that A. baumannii
has undertaken to become a pathogen capable of successfully infecting the human host.
Fig. 6. Proposed model of d-Lys production role in Acinetobacter spp. (A) The
lysine racemase RacK converts l-Lys to d-Lys in the periplasm. The presence of d-Lys
in the periplasmic space leads to PG editing by Ldts and PBPs in competition with
their canonical cross-link activity. This PG editing mechanism provides a form of
innate immunity against foreign PG targeting T6SS. PGase, Peptidoglycanase
(B) As a trade-off, secretion of d-Lys during infection increases host DAO activity and
thus decreases A. baumannii virulence. PGase, peptidoglycanase; OM, outer-membrane;
IM, inner-membrane.

RacK, and these strains are distributed across different clades in
the A. baumannii phylogeny (Fig. 5 and fig. S6). Thus, our results
indicate that RacK was encoded by the last common ancestor of
the Acb-complex and was lost multiple times independently during
A. baumannii evolution.
Our results are summarized in Fig. 6. During stationary phase,
the periplasmic racemase RacK catalyzes the conversion of l-Lys
to d-Lys. Once produced, d-Lys is incorporated into the PG of
Ab17978 by Ldt (l,d-transpeptidase) and penicillin-binding proteins
(PBPs) (22, 28–30). PG editing with d-Lys confers immunity to
T6SS-dependent attacks by reducing the specific activity of PG hydrolase effectors, such as Tse1. Because T6SS effectors recognize and
cleave conserved amide bonds in PG, we propose that certain types of
PG editing constitute an immunity mechanism against T6SS-dependent
killing. Previous work reported that l-DAP amidation in the PG
of the environmental bacterium Gluconobacter frateurii resulted in
reduced in vitro digestion by T6SS endopeptidases compared with
nonmodified PG (18). This mechanism of T6SS immunity is independent of immunity proteins, which bind with high specificity to
their cognate T6SS effectors. In contrast, PG editing–mediated immunity might protect against various T6SS effectors that recognize
canonical PG structures. We therefore propose that PG editing provides A. baumannii with a type of “innate immunity” against diverse
bacterial competitors. It is tempting to speculate that additional
common targets for T6SS effectors (or T7SS effectors in Gram-
positive bacteria) are also modified to evade the toxicity of these effectors. However, PG modification may not protect against all bacteria,
as the degree of protection may depend on the specific effectors secreted by different species.
Our data show that d-Lys production is unfavorable for A. baumannii
pathogenesis. We have shown that, in vitro, purified DAO is able to
recognize the d-Lys secreted by A. baumannii and produce enough
H2O2 to kill bacteria expressing RacK. DAO is known to be produced
by key players in the initial immune response against A. baumannii
Le et al., Sci. Adv. 2020; 6 : eabb5614
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MATERIALS AND METHODS

Bacterial strains and growth conditions
Bacterial strains used in this study are listed in table S5. Unless
otherwise noted, strains were grown in lysogeny broth (LB) liquid
medium at 37°C with shaking (200 rpm). The antibiotics rifampicin
(150 g/ml), irgasan (25 g/ml), kanamycin (7.5 or 50 g/ml),
gentamicin (20 g/ml), chloramphenicol (15 g/ml), carbenicillin
(100 or 200 g/ml), and zeocin (50 g/ml) were added when necessary. Spontaneous rifampicin-resistant mutant strains were obtained
by plating an overnight culture on LB agar with rifampicin.
PG isolation and analysis
PG from exponential and stationary cells from A. baumannii strains
was isolated and analyzed by HPLC as previously described (41, 42).
Briefly, A. baumannii strains were grown at 37°C in 500 ml of LB
media to a final OD600 (optical density at 600 nm) of 0.6 for exponential and grown for 24 hours for stationary phase samples. Cells
were collected by centrifugation for 15 min at 4°C and 7000g. Cell
pellets were resuspended in 50 ml of cold water and lysed by dropwise
addition to 50 ml of boiling 8% SDS under vigorous stirring. Samples
were boiled for further 30 min to ensure complete solubilization of
the membranes and degradation of the high–molecular weight DNA.
Crude PG samples were collected by ultracentrifugation for 60 min
at 110,000g at 25°C. Pellets were washed several times with phosphate
buffer (pH 6.0) to remove SDS. Crude PG samples were treated
with -amylase (1 mg/ml) for 1 hour at 37°C and then with Pronase
(2 mg/ml) for overnight at 60°C to remove trapped high–molecular
weight glycogen and PG-associated proteins, respectively. Further
PG preparation steps were performed as previously described (41).
Briefly, muropeptides were released from PG by the muramidase
cellosyl (Hoechst, Frankfurt am Main, Germany), reduced by sodium
borohydride, and separated on a 250 mm by 4.6 mm 3-m ProntoSIL
120-3-6C18 AQ reversed-phase column (Bischoff, Leonberg, Germany).
The eluted muropeptides were detected by their absorbance at 205 nm.
The PG composition from exponentially and stationary growing
cells was analyzed in two biological replicates. Muropeptides were
assigned according to their retention times of the known muropeptides from E. coli and A. baumannii (42) and quantified using the
Laura software (LabLogic Systems).
MS/MS analysis
New muropeptide fractions with retention times other than standard
muropeptides were collected and analyzed by tandem MS (MS/MS) as
5 of 8
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previously described (43). Linear trap quadrupole-Fourier transform
MS analyses revealed the presence of d-Lys in the collected muropeptide fractions c to e (fig. S7). Table S1 shows the proposed structures
and the theoretical neutral and measured neutral atomic mass units.
Muropeptide fractions a and b were also acetylated using an established protocol (17) prior MS/MS analysis to confirm the number of
amino groups.
Construction of A. baumannii mutant and
complement strains
The primers used in this study are listed in table S5. Mutants were
constructed as described previously (44). Briefly, an antibiotic resistance cassette was amplified with primers pair P1_kan Fwd-Rev
(Integrated DNA Technologies) with homology to the flanking
regions of the racK gene with additional 3′ 18 to 25 nucleotides of
homology to the FRT (FLP recognition target) site–flanked kanamycin resistance cassette from plasmid pKD4. This polymerase chain
reaction (PCR) product was electroporated into competent Ab17978
carrying pAT04, which expresses the RecAB recombinase (44).
Mutants were selected on kanamycin (10 g/ml), and integration
of the resistance marker was confirmed by PCR. To remove the
kanamycin resistance cassette, electrocompetent mutants were
transformed with pAT03 plasmid, which expresses the FLP recombinase. To create Ab17978 RacK+ strain, the racK gene was cloned
into pSH vector and under an arabinose inducible promotor, and
then the pSH_RacK plasmid was electroporated into Ab17978
RacK strain. The racK gene was introduced into UPAB1 via a
four-parent conjugal strategy as described by Kumar et al. (45).
Briefly, 100 l of stationary cultures were normalized to an OD600
of 2.0 of each recipient strain, and HB101(pRK2013), EC100D(pTNS2),
and EC100D containing the pUC-miniTn7-racK plasmid were
added to 600 l of warm LB. Each suspension was washed twice by
centrifugation at 7000g, followed by resuspension of the bacterial
pellet in 1 ml of warm LB. On the final wash, the bacterial pellet
was resuspended in 25 l of LB, and the suspension was spotted on
a prewarmed low-salt LB agar plate and incubated overnight at
37°C. The bacteria were scraped from the plate and resuspended
in 1 ml of LB and vortexed, and serial dilutions were plated on
L agar plates supplemented with chloramphenicol to select against
E. coli strains and kanamycin or zeocin to select for A. baumannii
strains that had received the mini-Tn7 constructs. To verify that
mini-Tn7 had successfully transposed downstream of the glmS2
gene, it is amplified by PCR using primers pair UPAB1_check
Fwd-Rev, and the products were verified by sequencing. The strains
were saved as Ab17978 RacK+ and UPAB1 RacK+.
Protein expression and purification
The amaD gene was PCR-amplified from P. putida and was cloned
in pET22b+ vector void of the pelB sequence using Hi-Fi DNA Assembly mix (New England Biolabs). The pET22b+_amaD vector was
electroporated into E. coli Rosetta II (Invitrogen) and selected on
carbenicillin. The bacteria were grown in LB to an OD600 of 0.6, and
AmaD protein expression was induced by the addition of 0.5 mM
isopropyl--d-thiogalactopyranoside for 3 hours at 30°C. Cells were
harvested and lysed with two rounds of a cell disruptor using
35 k.p.s.i. (Constant Systems Ltd., Kennesaw, GA). Cell lysates were
clarified at 10,000 rpm for 10 min and then were passed over a
nickel-nitrilotriacetic acid-agarose column Ni-NTA (GoldBio,
St. Louis, MO). Protein was eluted with 300 mM imidazole, buffer-
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exchanged using Sephadex G-25 PD10 column, and stored in 50 mM
tris-HCl (pH 8.0) and 150 mM NaCl at −80°C.
P. aeruginosa Tse1 protein was obtained as described (18). LdtA
from V. cholerae was obtained as described (22).
AmaD enzymatic assay
Bacteria cultures (3 ml) grown for 20 hours were centrifuged at
10,000g, and supernatants (0.5 ml) were collected. The supernatants
were deproteinized using Amicon Ultra 0.5-ml Centrifugal Filters
with 3000 MWCO (molecular weight cut-off). Samples were incubated
with AmaD (0.4 mg/ml) for 1 hour at 37°C. Hydrogen peroxide
coproduct was then measured using Hydrogen Peroxide Assay Kit
(Abcam) as instructed by the manufacturer.
Muropeptide isolation
TetraTetra and TetraTri-d-Lys were purified by HPLC on an Aeris
peptide column (250 mm by 4.6 mm; 3.6-m particle size; Pheno
menex, USA), concentrated, and desalted using a water-methanol
gradient on the same column before MS analysis. TetraTetra was
obtained from muramidase treatment of E. coli sacculi (46). Chroma
tographic analyses of muropeptides were performed on ACQUITY
Ultra Performance Liquid Chromatography (UPLC) BEH C18 column (130 Å, 1.7 m, 2.1 mm by 150 mm; Waters), and peptides were
detected at Abs. (absorbance) 204 nm using ACQUITY UPLC UV-
Visible Detector. Muropeptides were separated using a linear gradient from buffer A (0.1% of formic acid in water) to buffer B (0.1%
of formic acid in acetonitrile) for 18 min and flow (0.25 ml/min).
Muropeptide identity was confirmed by MS/MS analysis using a
Xevo G2-XS QTof system (Waters Corporation, USA). Quantification of muropeptides was based on their relative abundances (relative area of the corresponding peak).
In vitro reaction
TetraTri-d-Lys was obtained by mixing 10 g of TetraTetra with
20 mM d-Lys and 1 M LdtA for 4 hours in 20 mM tris (pH 8.0). PG
digestion was analyzed over time (0.5, 1, and 5 min) using a final
concentration of purified Tse1 enzyme (either 0.01 or 0.02 mg/ml)
from P. aeruginosa at 37°C in 20 mM tris-HCl (pH 8.0). The specific
activity was calculated from two independent experiments in duplicates (n = 4). The dataset resulting from the lower enzyme concentration (0.01 mg/ml; n = 2) was plotted to illustrate the differential
substrate consumption by Tse1 on canonical versus noncanonical
dimers. Individual muropeptides were quantified from their integrated
areas using samples of known concentration as standards. Reactions
were terminated by inactivation at 100°C for 10 min and centrifuged
at 14,000g for 30 min to discard the coagulated Tse1. Next, Tse1-
treated muropeptides were analyzed by UPLC. Determination of
the extent of Tse1-dependent degradation was performed by comparing the integration areas with respect to a nontreated sample.
T6SS competition assay
Competition assays were performed as previously described (47).
Briefly, predator and prey overnight cultures were pelleted, washed
three times in fresh LB, and resuspended at an OD600 of 1.0. The
cultures were mixed at a predator:prey ratio of 5:1 (PAO1:Ab or
M2:Ab) or 10:1 (Serratia:Ab), and 10 l of drops was spotted on a
LB 3% agar plate. After 4 hours at 37°C, the spots were harvested,
resuspended in 0.7 ml of LB, and serially diluted and plated on rifampicin or gentamicin LB agar plates to determine the number of
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surviving prey cells. In parallel, the number of surviving PAO1
predator was also enumerated on irgasan LB agar plates.
Murine model of A. baumannii acute pneumonia
All infection experiments were approved by the Vanderbilt University Institutional Animal Care and Use Committee and are in
compliance with the guidelines set by the Animal Welfare Act, the
National Institutes of Health, and the American Veterinary Medical
Association. Lung infection experiments were performed essentially
as previously described (32). Briefly, before infection, overnight cultures were subcultured 1:100 in 30 ml of liquid LB media and incubated at 37°C with shaking. Bacteria in mid-exponential phase growth
were harvested by centrifugation, washed twice with phosphate-
buffered saline (PBS), and resuspended in PBS to the same concentration. Anesthetized 7- to 9-week-old C57BL/6 mice (the Jackson
laboratory) were inoculated intranasally with 4 × 108 to 6 × 108 CFU
of Ab17978, UPAB1, or their respective isogenic mutants in 35 l of
PBS. Lungs, livers, spleens, kidneys, hearts, and blood were aseptically harvested from mice euthanized at 36 hours after infection.
Organs were homogenized and then serially diluted and plated to
LB agar to determine bacterial burdens.
DAO antimicrobial in vitro assay
Bacteria cultures (3 ml) grown for 20 hours were centrifuged at
10,000g, and supernatants (900 l) were collected. One hundred
microliters of fresh LB was added as well as purified porcine kidney
DAO and catalase (Millipore Sigma) to 50 and 25 g/ml, respectively.
The bacterial pellets were resuspended and added to the supernatant-
LB-DAO or DAO/catalase mixtures to an OD600 of 0.005. After
4.5 hours of incubation at 37°C, bacteria were serially diluted and
spotted on LB agar plates for enumeration.
Genome data
Genomic data used in this study were obtained from the National
Center for Biotechnology Information reference sequencing database
(version 87, accessed 13 March 2018). All 3052 Acinetobacter spp.
genome assemblies together with the corresponding coding and protein sequences were downloaded into a local database and integrated
in this analysis. To reduce the computational burden for tree reconstruction, we compiled a core set of 232 Acinetobacter spp. encompassing all described IC types of A. baumannii as well as type and
reference strains of 53 validly named species.
Phylogenetic profiling and synteny analysis
For all protein sequences, orthologous groups (OGs) across the 3052
genomes were inferred using a tandem of OMA (orthologous matrix)
standalone v. 2.2.0 (https://doi.org/10.1093/nar/gkx1019) and HaMStR
v. 13.2.9 (https://github.com/BIONF/hamstr, https://doi.org/10.1186/
1471-2148-9-157) as previously described (https://doi.org/10.1080/
21505594.2018.1558693). The synteny of racK and its two flanking
genes was inferred with the genomic loci of the corresponding orthologs using the gene order and orientation of the strain American
Type Culture Collection (ATCC) 17978 as a reference.
Phylogenetic tree reconstruction
The protein sequences of racK and its flanking genes in the core set
were aligned for each OG individually with MAFFT-linsi v7.407
(https://doi.org/10.1093/nar/gkt389). The resulting multiple sequence
alignment together with the corresponding coding sequences served
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then as input for PAL2NAL v.14 (https://doi.org/10.1093/nar/gkl315)
(with option “-codontable 11”) to generate corresponding codon
alignments. Individual or concatenated MSAs (multiple sequence alignment) were then used for a maximum likelihood tree reconstruction with
IQ-Tree v1.6.12 (https://doi.org/10.1093/nar/gkw256) performing 1000 nonparametric bootstrap replicates (https://doi.org/10.1093/
molbev/msx281). The best-fitting substitution model was determined
with the model-testing routines implemented into IQ-Tree (https://
doi.org/10.1038/nmeth.4285). Topology tests were performed using
the weighted and unweighted Shimodaira-Hasegawa test (https://
doi.org/10.1093/oxfordjournals.molbev.a026201) as implemented
in IQ-Tree.
MLST classification and IC assignments
We predicted for each of the 3052 Acinetobacter spp. strains the
sequence type with two different multilocus sequence typing (MLST)
schemes, Oxford (https://doi.org/10.1128/JCM.43.9.4382-4390.2005)
and Pasteur (https://doi.org/10.1371/journal.pone.0010034), that
we obtained from the PubMLST website (http://pubmlst.org/
abaumannii/) using MLSTcheck v2.1.17 (https://doi.org/10.21105/
joss.00118). Strains of A. baumannii were assigned to an IC type if
predicted sequence types and IC were unambiguously linked in the
literature (https://doi.org/10.1016/j.ijantimicag.2019.03.019,
https://doi.org/10.1016/j.meegid.2019.103986, https://doi.
org/10.1016/j.watres.2018.04.057, https://doi.org/10.1038/s41426018-0127-9, https://doi.org/10.1111/1462-2920.13931, https://doi.
org/10.1186/1471-2180-13-234, https://doi.org/10.1371/journal.
pone.0010034, https://doi.org/10.1371/journal.pone.0153014,
https://doi.org/10.1371/journal.pone.0179228, https://doi.
org/10.3389/fmicb.2019.00930, and https://doi.org/10.1186/
s13059-015-0701-6).
Statistical analysis
All statistical analyses were performed using GraphPad Prism
(GraphPad Software Inc., La Jolla, CA). For the murine acute pneumonia model, data were log-transformed and analyzed for Gaussian
distribution using the D’Agostino-Pearson omnibus normality test.
For normally distributed datasets, Student’s unpaired t tests were
used. For datasets with unknown distribution type, nonparametric
Mann-Whitney U tests were used.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/30/eabb5614/DC1
View/request a protocol for this paper from Bio-protocol.
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